Indiana Trust & Investment Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EPGL
RG
SAM
CDDEC
MGP
Indiana Trust & Investment Management's AZN Position: Q2 2026 in Review
Indiana Trust & Investment Management opened a new position in AstraZeneca (AZN) in Q2 2026: 420 shares worth $78.6K. The stake represents 0.02% of the portfolio and ranks #254 among its holdings. This is a return to the name: Indiana Trust & Investment Management previously reported a position in AZN as recently as Q4 2025.
Indiana Trust & Investment Management first reported a position in AZN in Q2 2024 and has held it in 8 quarters since. 880 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Indiana Trust & Investment Management held 420 shares of AstraZeneca worth $78.6K as of Q2 2026.
- AstraZeneca was a new Indiana Trust & Investment Management position in Q2 2026.
- AstraZeneca made up 0.02% of Indiana Trust & Investment Management's portfolio in Q2 2026, its #254 holding.
- Indiana Trust & Investment Management first reported a position in AstraZeneca in Q2 2024 and has held it in 8 quarters since.
- 880 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Indiana Trust & Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.